Inventor
GOUGEON MARIE-LISE
FR14 patents
⚠️ This page may combine multiple inventors who share the name “GOUGEON MARIE-LISE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PASTEUR INSTITUT
10 patentsUS8906634B2Dec 9, 2014
Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
PASTEUR INSTITUT10 citations90
US9164107B2Oct 20, 2015
HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders
PASTEUR INSTITUT4 citations82
US9164103B2Oct 20, 2015
Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
PASTEUR INSTITUT4 citations81
US9766254B2Sep 19, 2017
HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders
PASTEUR INSTITUT2 citations71
US10012655B2Jul 3, 2018
Method for quantitating total HMGB1 protein in biological samples
PASTEUR INSTITUT2 citations70
US12105095B2Oct 1, 2024
Assay to detect and quantitate specific antibodies for various redox forms of HMGB1
PASTEUR INSTITUT0 citations56
US11460473B2Oct 4, 2022
Assay to detect and quantitate specific an antibodies for various redox forms of HMGB1
PASTEUR INSTITUT0 citations56
US10018629B2Jul 10, 2018
Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
PASTEUR INSTITUT0 citations40
US9547006B2Jan 17, 2017
Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
PASTEUR INSTITUT1 citations40
US10890583B2Jan 12, 2021
Predictive value of Clostridium difficile-specific immune response for recurrence and disease outcome
PASTEUR INSTITUT0 citations39
GOUGEON MARIE-LISE
3 patentsUS8728748B2May 20, 2014
HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders
GOUGEON MARIE-LISE4 citations81
US8603766B2Dec 10, 2013
Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
GOUGEON MARIE-LISE5 citations79
US8450076B2May 28, 2013
Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
GOUGEON MARIE-LISE6 citations79